Abstract
This chapter provides basic information for quantifying soluble epidermal growth factor receptor (sEGFR) isoforms in human sera using an acridinium-linked immunosorbent assay (ALISA) developed by Baron and coworkers (1). This ALISA has been shown to be specific for epidermal growth factor receptor (EGFR) and the isoforms of EGFR encoded by alternate transcripts (i.e., sEGFRs); it, therefore, does not detect other EGFR/ErbB receptor family members, i.e., ErbB2, ErbB3, or ErbB4. In addition, this ALISA recognizes EGFR and sEGFR isoforms that contain subdomains I–IV of the extracellular domain, but it does not recognize EGFR isoforms lacking subdomain IV. The ALISA described here also may be useful for determining EGFR and sEGFR concentrations in lysates of cultured cells, conditioned culture medium, or tissue/tumor specimens, as well as in other human body fluids such as serum, plasma, ascites, urine, saliva, and cystic fluids.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baron A. T., Lafky J. M., Connolly D. C., et al. (1998) A sandwich typeacridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1(sErbB1) in normal human sera. J. Immunol. Methods 219, 23–43.
Ullrich A., Coussens L., Hayflick J. S., et al. (1984) Human epidermal growthfactor receptor cDNA sequence and aberrant expression of the amplified gene inA431 epidermoid carcinoma cells. Nature 309, 418–425.
Gullick W. J. (1991) Prevalence of aberrant expression of the epidermal growthfactor receptor in human cancers. Br. Med. Bull. 47, 87–98.
Prigent S. A. and Lemoine N. R. (1992) The type 1 (EGFR-related) family ofgrowth factor receptors and their ligands. Prog. Growth Factor Res. 4, 1–24.
Salomon D. S., Brandt R., Ciardiello, F., Normanno N. (1995) Epidermalgrowth factor-related peptides and their receptors in human malignancies. Crit.Rev. Oncol. Hematol. 19, 183–232.
Maihle N. J., Baron A. T., Barrette B. A., et al. (2002) EGF/ErbB receptor familyin ovarian cancer. Cancer Res. Treat. 107, 247–258.
Reiter J. L. and Maihle N. J. (1996) A 1.8 kb alternative transcript from thehuman epidermal growth factor receptor gene encodes a truncated form of thereceptor. Nucleic Acids Res. 24, 4050–4056.
Ilekis J. V., Stark B. C., Scoccia B. (1995) Possible role of variant RNAtranscripts in the regulation of epidermal growth factor receptor expression inhuman placenta. Mol. Reprod. Develop. 41, 149–156.
Reiter J. L., Threadgill D. W., Eley G. D., et al. (2001) Comparative genomicsequence analysis and isolation of human and mouse alternative EGFR transcriptsencoding truncated receptor isoforms. Genomics 71, 1–20.
Xu Y.-H., Richert N., Ito S., Merlino G. T., Pastan I. (1984) Characterizationof epidermal growth factor receptor gene expression in malignant and normalhuman cell lines. Proc. Natl. Acad. Sci. USA 81, 7308–7312.
Flickinger T. W., Maihle N. J., Kung H. J. (1992) An alternatively processedmRNA from the avian c-erbB gene encodes a soluble, truncated form ofthe receptor that can block ligand-dependent transformation. Mol. Cell. Biol. 12, 883–893.
Petch L. A., Harris J., Raymond V. W., Blasband A., Lee D. C., Earp H.S. (1990) A truncated, secreted form of the epidermal growth factor receptor isencoded by an alternatively spliced transcript in normal rat tissue. Mol. Cell. Biol. 10, 2973–2982.
Nieto-Sampedro M. and Broderick J. T. (1989) A soluble brain molecule relatedto epidermal growth factor receptor is a mitogen inhibitor for astrocytes. J.Neurosci. Res. 22, 28–35.
Cadena D. L. and Gill G. N. (1993) Expression and purification of the epidermalgrowth factor receptor extracellular domain utilizing a polycistronic expressionsystem. Protein Expr. Purif. 4, 177–186.
Basu A., Raghunath M., Bishayee, T., Das M. (1989) nhibition of tyrosinekinase activity of the epidermal growth factor (EGF) receptor by a truncated receptorform that binds to EGF: role for interreceptor interaction in kinase regulation. Mol. Cell. Biol. 9, 671–677.
Weeks I., Sturgess M., Brown R. C., Woodhead J. S. (1986) mmunoassaysusing acridinium esters. Methods Enzymol. 133, 366–387.
Waterfield M. D., Mayes E. L., Stroobant P., et al. (1982) A monoclonal antibodyto the human epidermal growth factor receptor. J. Cell. Biochem. 20, 149–161.
Sato J. D., Kawamoto T., Le A. D., Mendelsohn J., Polikoff J., Sato G. H.,(1983) Biological effects in vitro of monoclonal antibodies to human epidermalgrowth factor receptors. Mol. Biol. Med. 1, 511–529.
Baron A. T., Greenwood T. M., Bazinet C. W., Salisbury J. L., (1992) Centrin is a component of the pericentriolar lattice. Biol. Cell 76, 383–388.
Rodbard D. (1978) Statistical estimation of the minimal detectable concentration(“sensitivity”) for radioligand assays. Anal. Biochem. 90, 1–12.
Spencer C. A., Takeuchi M., Kazarosyan M., MacKenzie F., Beckett G. J., and Wilkinson E. (1995) nterlaboratory/intermethod differences in functional sensitivityof immunometric assays of thyrotropin (TSH) and impact on reliability ofmeasurement of subnormal concentration of TSH. Clin. Chem. 41, 367–374.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Lafky, J.M., Baron, A.T., Maihle, N.J. (2006). Soluble Epidermal Growth Factor Receptor Acridinium-Linked Immunosorbent Assay. In: Patel, T.B., Bertics, P.J. (eds) Epidermal Growth Factor. Methods in Molecular Biology, vol 327. Humana Press. https://doi.org/10.1385/1-59745-012-X:39
Download citation
DOI: https://doi.org/10.1385/1-59745-012-X:39
Publisher Name: Humana Press
Print ISBN: 978-1-58829-421-0
Online ISBN: 978-1-59745-012-6
eBook Packages: Springer Protocols